# Study of Metformin With Simvastatin for Men With Prostate Carcinoma

> **NCT01561482** · PHASE2 · WITHDRAWN · sponsor: **Nicholas Mitsiades**

## Conditions studied

- Prostate Carcinoma

## Interventions

- **DRUG:** Metformin
- **DRUG:** Simvastatin

## Key facts

- **NCT ID:** NCT01561482
- **Lead sponsor:** Nicholas Mitsiades
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-01
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study closed due to slow/low enrollment; no subjects were enrolled.
- **Last updated:** 2015-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01561482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01561482, "Study of Metformin With Simvastatin for Men With Prostate Carcinoma". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT01561482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*